Annual report pursuant to Section 13 and 15(d)

LICENSE AGREEMENTS (Details)

v3.21.2
LICENSE AGREEMENTS (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 03, 2020
Oct. 23, 2020
Aug. 04, 2017
Oct. 31, 2020
Mar. 31, 2020
Jun. 30, 2021
License Agreements            
Stock Issued During Period, Value, Issued for Services           $ 8
License agreement            
License Agreements            
Stock Issued During Period, Value, Issued for Services         $ 2,600  
Activesite Pharmaceuticals Inc            
License Agreements            
Milestone Payments $ 1,000          
Maximum Amount of Milestone Events     $ 46,500      
First milestone payment due after completion of the preclinical work     $ 1,000      
Royalties percentage     2.00%      
Xoma            
License Agreements            
Proceeds from private placement of equity shares       $ 41,000    
Payments of outstanding balance of license   $ 1,400        
Milestone Payments           $ 37,000
Xoma | License agreement            
License Agreements            
Stock Issued During Period, Shares, Other           162,000